2017
DOI: 10.1002/ange.201609395
|View full text |Cite
|
Sign up to set email alerts
|

Peptide N‐Amination Supports β‐Sheet Conformations

Abstract: The conformational heterogeneity of backbone Nsubstituted peptides limits their ability to adopt stable secondary structures.H erein, we describe ap ractical synthesis of backbone aminated peptides that readily adopt b-sheet folds. Data derived from model N-amino peptides suggest that extended conformations are stabilized through cooperative steric, electrostatic,and hydrogen-bonding interactions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 48 publications
0
10
0
Order By: Relevance
“…One way to mitigate these issues could be macrocyclization of the peptide; however, this could also change its shape and function, much like removing the macrocycle from depsidomycin could have changed its function. Because of these issues with peptide-based drugs, many groups have devoted their research to making peptidomimetics, or peptide-like molecules, which includes: β- or γ-peptides [78,79], peptoids [80,81], spiroligomers [82,83], stapled peptides [84,85], and N-amino peptides [86,87] among many others. As there is much work on overcoming the issues associated with peptide-based drugs/therapeutics, it is important to remember new peptide-based therapeutics or diagnostics must possess an inherent ability to circumvent the immune system’s native defenses against foreign peptides or peptide fragments.…”
Section: Extracellular Targetsmentioning
confidence: 99%
“…One way to mitigate these issues could be macrocyclization of the peptide; however, this could also change its shape and function, much like removing the macrocycle from depsidomycin could have changed its function. Because of these issues with peptide-based drugs, many groups have devoted their research to making peptidomimetics, or peptide-like molecules, which includes: β- or γ-peptides [78,79], peptoids [80,81], spiroligomers [82,83], stapled peptides [84,85], and N-amino peptides [86,87] among many others. As there is much work on overcoming the issues associated with peptide-based drugs/therapeutics, it is important to remember new peptide-based therapeutics or diagnostics must possess an inherent ability to circumvent the immune system’s native defenses against foreign peptides or peptide fragments.…”
Section: Extracellular Targetsmentioning
confidence: 99%
“…We recently described an approach to b-strand stabilization based on peptide backbone N-amination (Figure 1C). 41 The conformational and non-aggregating characteristics of Namino peptides (NAPs) are consistent across distinct models of b-sheet folding and are attributed to cooperative non-covalent interactions involving the Na-NH2 substituent. Here, we describe the design and synthesis of NAPs that block tau fibrilization and spread in a sequence-specific manner.…”
Section: Introductionmentioning
confidence: 96%
“… 30 This problem might be solved by utilizing N -protected electrophilic amination reagents that form hydrazines that are stable under reaction conditions, but this requires a further deprotection step. 25 , 31 , 32 Transformation with commercially available amination reagents that form unprotected hydrazine has practical advantages. Here we report a fast and straightforward method for the preparation of pyrazoles from primary aliphatic and aromatic amines as limiting reagents using bench-stable, commercially available amination reagent.…”
Section: Introductionmentioning
confidence: 99%